VAERS Explorer
Back to explore

Report #2884026

Received Feb 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
70 yrs
State
NY
Recovered
Not recovered
Vaccinated
Jan 12, 2026
Onset
Jan 1, 2026
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNKLA

Symptoms (5)

ArthralgiaChillsMobility decreasedMyalgiaPain

Symptom narrative

Aching joints/Aching in knees; Muscle ache; Chills; body aches; difficult time getting up and sitting down due to the ache in her knees; This non-serious case was reported by a consumer via call center representative and described the occurrence of joint pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included myalgic encephalomyelitis (Myalgic encephalomyelitis) and chronic fatigue. Concomitant products included evolocumab (Repatha), levothyroxine, liothyronine (Np Thyroid), magnesium hydroxide (Magnesium) and berberine hydrochloride (Berberine). On 12-JAN-2026, the patient received the 2nd dose of Shingrix (left arm) .5 ml. On 13-JAN-2026, 1 days after receiving Shingrix, the patient experienced joint pain (Verbatim: Aching joints/Aching in knees), muscle pain (Verbatim: Muscle ache), chills (Verbatim: Chills) and general body pain (Verbatim: body aches). In JAN-2026, the patient experienced mobility decreased (Verbatim: difficult time getting up and sitting down due to the ache in her knees). On 14-JAN-2026, the outcome of the chills was resolved (duration 1 day). The outcome of the joint pain, muscle pain, general body pain and mobility decreased were not resolved. It was unknown if the reporter considered the joint pain, muscle pain, chills, general body pain and mobility decreased to be related to Shingrix. It was unknown if the company considered the joint pain, muscle pain, chills, general body pain and mobility decreased to be related to Shingrix. Additional Information: GSK Receipt Date: 28-JAN-2026 The reporter was the patient. The reporter stated that she received her second dose of Shingrix approximately 2 weeks ago. Twenty-four hours after receiving the vaccine in her left arm the patient had chills body aches muscle aches. The chills resolved in twenty-four hours. All other symptoms persist. The reporter stated the worse aching in her knees. The reporter was having a difficult time getting up and sitting down due to the ache in her knees. The batch number was not provided and request for this information has been made.

Current illness

Chronic fatigue; Myalgic encephalomyelitis (Myalgic encephalomyelitis)

Other medications

REPATHA; NP THYROID; MAGNESIUM; BERBERINE